Does Wegovy Make You Sad or Affect Your Mood?

The decision you're facing: is the mood risk real enough to matter?

This is the right question to ask, and it deserves a straight answer. The summary is: the risk exists and is taken seriously by regulators, but for most people it is not the dominant experience on treatment. Wegovy's prescribing information lists depression and mood changes as potential side effects, and the NHS advises patients to watch for them — you can read the full guidance on the NHS semaglutide medicines page. The MHRA keeps post-market safety data under ongoing review for all GLP-1 medicines, which is why Wegovy still carries a Black Triangle (▼), meaning regulators continue to collect reports.

What the large trials did not show is a statistically clear causal relationship between semaglutide and clinical depression at the population level. The STEP 1 trial, published in the New England Journal of Medicine, monitored mental-health outcomes as part of its safety data and did not find a signal. That does not mean no individual experiences low mood, it means, on current evidence, most do not. Individual responses vary, and there are plausible biological reasons why both directions are possible, which the next two sections cover.

If you have a history of depression or another serious mental-health condition, that is not a flat barrier to treatment, but it is exactly the kind of detail a prescriber needs to know about before writing a prescription. It shapes the conversation, not the conclusion.

Why some people feel emotionally worse, and why some feel better

Semaglutide slows gastric emptying and acts on GLP-1 receptors that exist not just in the gut but in the brain. The central effects are part of why appetite falls, the brain receives satiety signals differently. Those same pathways may, in some people, influence mood, motivation, or the reward response to food. For people whose relationship with eating was emotionally significant, losing that pleasure abruptly can feel disorienting. A few patients describe a kind of flatness: less enjoyment of meals, less social spontaneity around food, and sometimes a generalised emotional blunting. That is a real experience worth acknowledging.

On the other side, many people report an unexpected lift in mood within the first weeks. Possible reasons include: reduced blood-sugar fluctuations (which can themselves cause low mood and irritability), improved sleep as weight comes off, and simply the psychological relief of seeing progress after years of difficulty. How Wegovy makes you feel overall is a genuinely mixed picture, shaped heavily by your starting point, your mental-health history, and what else is happening in your life. There is also a body of early research exploring GLP-1 receptors in mood regulation, but it is not yet at a stage where clinical conclusions can be drawn.

Other physical side effects can compound emotional strain indirectly. Persistent nausea is demoralising. Fatigue in the early weeks can look like low mood. If you feel weak or unusually tired alongside a low emotional state, that is a conversation for your prescriber, fatigue and weakness on Wegovy are covered separately.

When to seek help and what to report

The NHS and MHRA are clear: if you develop depression, notice a significant change in mood, or have any thoughts of self-harm or suicide while taking Wegovy, tell a healthcare professional straight away. Do not wait to see whether it passes. Stop the injection and seek urgent help if you feel you might harm yourself. This is not a theoretical precaution, it reflects the same standard applied to many medicines that act on neurological pathways.

For less acute concerns, the right first step is your prescriber or GP. At nume, our clinical team is available for aftercare seven days a week, so you do not need to wait until the following Monday to flag something that is bothering you. Timing matters: low mood that appears after a dose increase, for example, is different from something that has been present for months and predates treatment. Note when changes started and whether anything else shifted at the same time.

Patients can also report suspected side effects directly using the MHRA's Yellow Card scheme. This feeds into the ongoing pharmacovigilance that keeps the safety picture current. If you are supporting the data, you are supporting the next person who asks this question.

Practical things worth knowing before you decide

Mental-health history should be part of your consultation form, not a barrier, but a signal for the prescriber to tailor their approach. If you are currently on an antidepressant or mood stabiliser, your prescriber needs to know, partly because Wegovy slows gastric emptying and may affect how other oral medicines are absorbed.

Some people find it useful to track their mood in a simple notes app during the first few weeks on treatment. A prescriber asking "have you noticed any mood changes?" gets a much better answer from someone with a brief log than from someone trying to recall eight weeks at once. A question our prescribers hear regularly: "Is this the medicine or is this just a hard month?" Having a record helps answer it. If you want to understand more about the company behind the medication, our page on who owns Wegovy and how it came to market gives useful background context. If you happen to start treatment after a disrupted period (around the holidays or a particularly stressful run) baseline mood is already harder to read, so the log matters more.

To get a fuller picture of what semaglutide is and how the two licensed UK forms work, the semaglutide overview is a good starting point, and the Wegovy treatment page covers the practical details. Some people also ask whether physical warmth or flushing is part of the experience, and if that is something you have noticed, our page on whether Wegovy makes you feel hot addresses that directly. When you're ready to discuss your own situation with a prescriber, check your eligibility with our clinical team, there's no charge for the consultation.